Loading...
CSL Limited
CMXHF•PNK
Healthcare
Biotechnology
$107.40
$0.00(0.00%)
U.S. Market opens in 9h 38mCSL Limited (CMXHF) AI-Powered Stock Analysis
See how CSL Limited scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerCSL Limited (CMXHF) Stock Overall Grade
CSL Limited’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to CSL Limited's overall stock rating.
Forecast
A+Score
91/100Financial Growth
B+Score
75/100Fundamental Growth
AScore
84/100Key Ratios
B+Score
74/100Sector Comparison
A+Score
100/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
96/100Analyst Consensus
BScore
63/100CSL Limited (CMXHF) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 91/100 (A+), reflecting high confidence in its potential. Financial Growth (75/100, B+) and Fundamental Growth (84/100, A) highlight its stability, while Key Ratios (74/100, B+) and Sector Comparison (100/100, A+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (96/100, A+), it shows competitive strength. Analyst Consensus (63/100,B) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each CSL Limited stock grade, including financials, comparisons, and forecasts.